PROGNOSIS OF DYNAMIC MR IMAGING AND DIFFUSION WEIGHTED IMAGING FOR STAGE III NON-SMALL CELL LUNG CANCER PATIENTS TREATED WITH CONCURRENT CHEMO-RADIOTHERAPY

被引:0
|
作者
Li, Baosheng [1 ]
Wang, Yinxia [1 ]
Chen, Zhaoqiu [1 ]
机构
[1] Shandong Canc Hosp, Jinan, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
304
引用
收藏
页码:158 / 158
页数:1
相关论文
共 50 条
  • [21] Managing the care of patients receiving concurrent chemo-radiotherapy for non-small cell lung cancer-lan overview
    Halkyard, E.
    Fenemore, J.
    LUNG CANCER, 2012, 75 : S34 - S35
  • [22] Prognostic value of PDL1 expression in stage III Non-Small Cell Lung Cancer (NSCLC) treated by chemo-radiotherapy (CRT)
    Adam, J.
    Boros, A.
    Lacas, B.
    Lacroix, L.
    Pignon, J. P.
    Caramella, C.
    Planchard, D.
    Levy, A.
    Besse, B.
    Le Pechoux, C.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S604 - S604
  • [23] Individualized accelerated isotoxic concurrent chemo-radiotherapy for stage III non-small cell lung cancer: 5-Year results of a prospective study
    De Ruysscher, Dirk
    van Baardwijk, Angela
    Wanders, Rinus
    Hendriks, Lizza E.
    Reymen, Bait
    van Empt, Wouter
    Ollers, Michel C.
    Bootsma, Gerben
    Pitz, Cordula
    van Eijsden, Linda
    Dingemans, Anne-Marie C.
    RADIOTHERAPY AND ONCOLOGY, 2019, 135 : 141 - 146
  • [24] A single-centre experience of adjuvant Durvalumab in patients with Non-small cell lung cancer (NSCLC) treated with radical concurrent chemo-radiotherapy
    Hussnain, Ali
    Button, Mick
    Iqbal, Sahar Najmus
    Powell, Ceri
    Cox, Samantha
    Namelo, Clara
    Shaw, Paul
    Chan, Po
    LUNG CANCER, 2024, 190
  • [25] The prognostic impact of supraclavicular lymph node in N3-IIIB stage non-small cell lung cancer patients treated with definitive concurrent chemo-radiotherapy
    Oh, Dongryul
    Ahn, Yong Chan
    Park, Hee Chul
    Lim, Do Hoon
    Noh, Jae Myoung
    Cho, Won Kyung
    Pyo, Hongryull
    ONCOTARGET, 2017, 8 (22) : 35700 - 35706
  • [26] Second primary cancers in patients with stage III non-small cell lung cancer successfully treated with chemo-radiotherapy.
    Kawaguchi, T
    Ogawara, M
    Kawahara, M
    Fukai, S
    Komatsu, H
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 697S - 697S
  • [27] Vinorelbine-based chemo-radiotherapy in non-small cell lung cancer
    Scotti, Vieri
    Saieva, Calogero
    Di Cataldo, Vanessa
    Bruni, Alessio
    Desideri, Isacco
    Bertocci, Silvia
    Meattini, Icro
    Livi, Lorenzo
    Simontacchi, Gabriele
    Cardillo, Carla De Luca
    Bendinelli, Benedetta
    Bastiani, Paolo
    Mangoni, Monica
    Agresti, Benedetta
    Biti, Giampaolo
    TUMORI, 2012, 98 (04) : 464 - 470
  • [28] Value of lung perfusion in stage III non-small cell lung cancer patients treated with radiotherapy
    Li, B.
    Wang, Z.
    Yin, Y. O. N. G.
    Yang, G.
    Fu, Z.
    Hu, X.
    Yan, J. I. N. G.
    Zhou, T. A. O.
    EJC SUPPLEMENTS, 2007, 5 (04): : 382 - 382
  • [29] Use of chemo-radiotherapy in locally advanced non-small cell lung cancer
    Novello, S
    Le Chevalier, T
    EUROPEAN JOURNAL OF CANCER, 2002, 38 (02) : 292 - 299
  • [30] Salvage surgery after definitive chemo-radiotherapy for patients with Non-Small Cell Lung Cancer
    Romero-Vielva, Laura
    Viteri, Santiago
    Moya-Horno, Irene
    Ignacio Toscas, Jose
    Antonio Maestre-Alcacer, Jose
    Ramon y Cajal, Santiago
    Rosell, Rafael
    LUNG CANCER, 2019, 133 : 117 - 122